Start SIP in ARVEE
Start SIPPerformance
- Low
- ₹159
- High
- ₹164
- 52 Week Low
- ₹117
- 52 Week High
- ₹315
- Open Price₹161
- Previous Close₹161
- Volume378
Investment Returns
- Over 1 Month -13.11%
- Over 3 Month -17.29%
- Over 6 Month -9.57%
- Over 1 Year + 3.79%
Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!
Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 78
- PEG Ratio
- 2
- Market Cap Cr
- 178
- P/B Ratio
- 6.1
- Average True Range
- 8.91
- EPS
- 2.07
- Dividend Yield
- 0
- MACD Signal
- -4.28
- RSI
- 42.68
- MFI
- 46.4
Arvee Laboratories (India) Financials
Arvee Laboratories (India) Technicals
EMA & SMA
Current Price
₹161.19
+
0.43
(0.27%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹167.24
- 50 Day
- ₹172.36
- 100 Day
- ₹175.30
- 200 Day
- ₹173.65
Resistance and Support
161.37
- R3 169.85
- R2 167.08
- R1 164.14
- S1 158.43
- S2 155.66
- S3 152.72
Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results & Others | To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-. |
2024-08-13 | Quarterly Results | |
2024-02-13 | Quarterly Results | (Revised) issue in the ratio of 1:1 of Rs. 10/-. |
2023-11-07 | Quarterly Results | |
2023-08-11 | Quarterly Results |
Arvee Laboratories (India) F&O
About Arvee Laboratories (India)
- NSE Symbol
- ARVEE
- BSE Symbol
- Managing Director
- Mr. Shalin Sudhakarbhai Patel
- ISIN
- INE006Z01016
Similar Stocks to Arvee Laboratories (India)
Arvee Laboratories (India) FAQs
Arvee Laboratories (India) share price is ₹161 As on 20 January, 2025 | 06:58
The Market Cap of Arvee Laboratories (India) is ₹177.6 Cr As on 20 January, 2025 | 06:58
The P/E ratio of Arvee Laboratories (India) is 78 As on 20 January, 2025 | 06:58
The PB ratio of Arvee Laboratories (India) is 6.1 As on 20 January, 2025 | 06:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.